Analysts Expect Brickell Biotech, Inc. (NASDAQ:BBI) to Post -$0.06 EPS

Analysts expect Brickell Biotech, Inc. (NASDAQ:BBI – Get Rating) to announce earnings of ($0.06) per share for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Brickell Biotech’s earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.05). Brickell Biotech reported earnings per share of ($0.15) during the same […]

Related Keywords

United States ,William Blair ,Morgan Stanley ,Brickell Biotech Inc ,Geode Capital Management ,Zacks Investment Research ,Blackrock Inc ,Nasdaq ,Capital Partners ,Brickell Biotech Company Profile Get Rating ,Citadel Advisors ,Brickell Biotech ,Get Rating ,Investment Research ,Capital Management ,Xbiotech Company Profile ,Nasdaq Bbi ,Bbi ,Medical ,Ratings ,Consensus ,